Alzheimer’s disease is a debilitating condition that currently has no cure and no effective treatment,” says Dr. Harry Croft, psychiatrist at CTT.
San Antonio, TX (PRWEB) March 25, 2015
New medications for the treatment of Alzheimer’s haven’t hit the market in more than a decade, but local researchers at Clinical Trials of Texas (CTT) are hoping to change this.
“Alzheimer’s disease is a debilitating condition that currently has no cure and no effective treatment,” says Dr. Harry Croft, psychiatrist at CTT. “If we were able to prove that these new medications we are testing work, this would absolutely be revolutionary for the treatment of Alzheimer’s moving forward.”
Many pharmaceutical companies have tested medications for Alzheimer’s in the past several years, but none of them were proven effective, that is until now.
Several trials being conducted across the country are showing promise for new Alzheimer’s medications including the new drug called T-817MA, which is designed to protect nerve cells in the brain.
“The new medication, T-817MA is showing promising results for those with mild to moderate Alzheimer’s,” says Croft. “We are also currently testing another medication that we believe may reduce the buildup of amyloid plaque in the brain, which may contribute to the onset of Alzheimer’s.”
With an aging population and a serious need to find a treatment option, Croft and his colleagues remain hopeful of what the future may bring.
“The important thing to remember with these medications and all others is that in order to test effectiveness and safety, we need volunteers,” Croft says. “If you or a loved one is experiencing memory loss or have early stage Alzheimer’s, give us a call to see how you can help.”
For more information on currently enrolling Alzheimer’s studies at Clinical Trials of Texas, call 210.949.0122 or visit their website at SAresearch.com.
About Clinical Trials of Texas
Clinical Trials of Texas (CTT) is one of the leading clinical research organizations in the state. With over 50 board certified physicians, and new Phase I facility, CTT conducts studies in a multitude of therapeutic areas, phases and design types. Working with major pharmaceutical and device sponsors, CRO’s, as well as smaller bio-tech companies, CTT successfully and safely continues to lead the way in advanced clinical research. To learn more or to participate in a research study, visit SAresearch.com.